Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2003 Dec;12(6):355–359. doi: 10.1080/09629350310001633397

Role of soluble gp130 in the tumour necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.

E Jablonskaca 1, W Puzewska 1, M Marcinczyk 1, J Jablonski 1
PMCID: PMC1781630  PMID: 14668095

Full Text

The Full Text of this article is available as a PDF (210.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aukrust P., Ueland T., Lien E., Bendtzen K., Müller F., Andreassen A. K., Nordøy I., Aass H., Espevik T., Simonsen S. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1999 Feb 1;83(3):376–382. doi: 10.1016/s0002-9149(98)00872-8. [DOI] [PubMed] [Google Scholar]
  2. Bank U., Küpper B., Reinhold D., Hoffmann T., Ansorge S. Evidence for a crucial role of neutrophil-derived serine proteases in the inactivation of interleukin-6 at sites of inflammation. FEBS Lett. 1999 Nov 19;461(3):235–240. doi: 10.1016/s0014-5793(99)01466-0. [DOI] [PubMed] [Google Scholar]
  3. Dahmen H., Horsten U., Küster A., Jacques Y., Minvielle S., Kerr I. M., Ciliberto G., Paonessa G., Heinrich P. C., Müller-Newen G. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. Biochem J. 1998 May 1;331(Pt 3):695–702. doi: 10.1042/bj3310695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fernandez-Botran Rafael, Crespo Fabian A., Sun Xichun. Soluble cytokine receptors in biological therapy. Expert Opin Biol Ther. 2002 Aug;2(6):585–605. doi: 10.1517/14712598.2.6.585. [DOI] [PubMed] [Google Scholar]
  5. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991 Dec 1;147(11):3815–3822. [PubMed] [Google Scholar]
  6. Igaz P., Tóth S., Rose-John S., Madurka I., Fejér G., Szalai C., Falus A. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes. Cytokine. 1998 Aug;10(8):620–626. doi: 10.1006/cyto.1997.0330. [DOI] [PubMed] [Google Scholar]
  7. Jablonska E. Effect of soluble interleukin-6 receptor alpha and interleukin-6 secreted by polymorphonuclear leukocytes on tumor necrosis factor-alpha expression and its production by peripheral blood mononuclear cells. Mediators Inflamm. 2002 Oct;11(5):325–328. doi: 10.1080/09629350210000015746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jones Simon A., Rose-John Stefan. The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. Biochim Biophys Acta. 2002 Nov 11;1592(3):251–263. doi: 10.1016/s0167-4889(02)00319-1. [DOI] [PubMed] [Google Scholar]
  9. Jostock T., Müllberg J., Ozbek S., Atreya R., Blinn G., Voltz N., Fischer M., Neurath M. F., Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem. 2001 Jan;268(1):160–167. doi: 10.1046/j.1432-1327.2001.01867.x. [DOI] [PubMed] [Google Scholar]
  10. Kisseleva T., Bhattacharya S., Braunstein J., Schindler C. W. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 2002 Feb 20;285(1-2):1–24. doi: 10.1016/s0378-1119(02)00398-0. [DOI] [PubMed] [Google Scholar]
  11. Modur V., Li Y., Zimmerman G. A., Prescott S. M., McIntyre T. M. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest. 1997 Dec 1;100(11):2752–2756. doi: 10.1172/JCI119821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Müllberg J., Geib T., Jostock T., Hoischen S. H., Vollmer P., Voltz N., Heinz D., Galle P. R., Klouche M., Rose-John S. IL-6 receptor independent stimulation of human gp130 by viral IL-6. J Immunol. 2000 May 1;164(9):4672–4677. doi: 10.4049/jimmunol.164.9.4672. [DOI] [PubMed] [Google Scholar]
  13. Müller-Newen G., Küster A., Hemmann U., Keul R., Horsten U., Martens A., Graeve L., Wijdenes J., Heinrich P. C. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J Immunol. 1998 Dec 1;161(11):6347–6355. [PubMed] [Google Scholar]
  14. Oh J. W., Van Wagoner N. J., Rose-John S., Benveniste E. N. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. J Immunol. 1998 Nov 1;161(9):4992–4999. [PubMed] [Google Scholar]
  15. Rose-John Stefan. GP130 stimulation and the maintenance of stem cells. Trends Biotechnol. 2002 Oct;20(10):417–419. doi: 10.1016/s0167-7799(02)02056-5. [DOI] [PubMed] [Google Scholar]
  16. Timmermann A., Pflanz S., Grötzinger J., Küster A., Kurth I., Pitard V., Heinrich P. C., Müller-Newen G. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor. FEBS Lett. 2000 Feb 25;468(2-3):120–124. doi: 10.1016/s0014-5793(00)01205-9. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES